Plant based drug designing for diabetes mellitus type-ii using pergularia daemia extract and its phytochemical pentacosanoic acid

摘要

The present invention relates to the plant based drug designing performed for the treatment of Diabetes mellitus Type 1 and 2 using plant extracts from the plant species Pergularia daemia (Forssk.) Chiov. The plant used is a hispid, perennial vine in the Apocynaceae family. The extracts comprise phytochemical, in particular Pentacosanoic acid which is used for treatment of Type 1 diabetes and Type 2 Diabetes mellitus. Plant based drug is less toxic and free from side effects than synthetic medicaments. There are considerable economic benefits in the use of medicinal plants for the treatment of Diabetes mellitus. Hence the plant extract of Pergularia daemia and its phytochemicals may enable the design of less expensive therapies that can control, treat, and prevent Diabetes mellitus.